Literature DB >> 19270713

CD98hc facilitates B cell proliferation and adaptive humoral immunity.

Joseph Cantor1, Cecille D Browne, Raphael Ruppert, Chloé C Féral, Reinhard Fässler, Robert C Rickert, Mark H Ginsberg.   

Abstract

The proliferation of antigen-specific lymphocytes and resulting clonal expansion are essential for adaptive immunity. We report here that B cell-specific deletion of the heavy chain of CD98 (CD98hc) resulted in lower antibody responses due to total suppression of B cell proliferation and subsequent plasma cell formation. Deletion of CD98hc did not impair early B cell activation but did inhibit later activation of the mitogen-activated protein kinase Erk1/2 and downregulation of the cell cycle inhibitor p27. Reconstitution of CD98hc-deficient B cells with CD98hc mutants showed that the integrin-binding domain of CD98hc was required for B cell proliferation but that the amino acid-transport function of CD98hc was dispensable for this. Thus, CD98hc supports integrin-dependent rapid proliferation of B cells. We propose that the advantage of adaptive immunity favored the appearance of CD98hc in vertebrates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270713      PMCID: PMC2672195          DOI: 10.1038/ni.1712

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  49 in total

1.  Convergence between CD98 and integrin-mediated T-lymphocyte co-stimulation.

Authors:  A P Warren; K Patel; Y Miyamoto; J N Wygant; D G Woodside; B W McIntyre
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 2.  Integrin-dependent signal transduction regulating cyclin D1 expression and G1 phase cell cycle progression.

Authors:  Janice L Walker; Richard K Assoian
Journal:  Cancer Metastasis Rev       Date:  2005-09       Impact factor: 9.264

3.  B cell ligand discrimination through a spreading and contraction response.

Authors:  S J Fleire; J P Goldman; Y R Carrasco; M Weber; D Bray; F D Batista
Journal:  Science       Date:  2006-05-05       Impact factor: 47.728

Review 4.  mTOR at the crossroads of T cell proliferation and tolerance.

Authors:  Anna Mondino; Daniel L Mueller
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

Review 5.  The evolution of adaptive immune systems.

Authors:  Max D Cooper; Matthew N Alder
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

6.  Distinct domains of CD98hc regulate integrins and amino acid transport.

Authors:  C A Fenczik; R Zent; M Dellos; D A Calderwood; J Satriano; C Kelly; M H Ginsberg
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

7.  CD98hc (SLC3A2) mediates integrin signaling.

Authors:  Chloe C Feral; Naoyuki Nishiya; Csilla A Fenczik; Heidi Stuhlmann; Marina Slepak; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

8.  CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation.

Authors:  Neil C Henderson; Elizabeth A Collis; Alison C Mackinnon; Kenneth J Simpson; Christopher Haslett; Roy Zent; Mark Ginsberg; Tariq Sethi
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

Review 9.  Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression.

Authors:  R K Assoian; M A Schwartz
Journal:  Curr Opin Genet Dev       Date:  2001-02       Impact factor: 5.578

Review 10.  Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways.

Authors:  M A Schwartz; R K Assoian
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  42 in total

Review 1.  The SLC38 family of sodium-amino acid co-transporters.

Authors:  Stefan Bröer
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657

2.  CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.

Authors:  Soline Estrach; Sin-Ae Lee; Etienne Boulter; Sabrina Pisano; Aurélia Errante; Floriane S Tissot; Laurence Cailleteau; Catherine Pons; Mark H Ginsberg; Chloé C Féral
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

Review 3.  Metabolic Regulation of the Immune Humoral Response.

Authors:  Mark Boothby; Robert C Rickert
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

4.  Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity.

Authors:  Joseph Cantor; Marina Slepak; Nil Ege; John T Chang; Mark H Ginsberg
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 5.  Molecular programming of B cell memory.

Authors:  Michael McHeyzer-Williams; Shinji Okitsu; Nathaniel Wang; Louise McHeyzer-Williams
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

6.  CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.

Authors:  Jeevisha Bajaj; Takaaki Konuma; Nikki K Lytle; Hyog Young Kwon; Jailal N Ablack; Joseph M Cantor; David Rizzieri; Charles Chuah; Vivian G Oehler; Elizabeth H Broome; Edward D Ball; Edward H van der Horst; Mark H Ginsberg; Tannishtha Reya
Journal:  Cancer Cell       Date:  2016-10-27       Impact factor: 31.743

Review 7.  Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98.

Authors:  Hang Thi Thu Nguyen; Didier Merlin
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

8.  Ubiquitylation of CD98 limits cell proliferation and clonal expansion.

Authors:  Jailal N G Ablack; Patrick J Metz; John T Chang; Joseph M Cantor; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2015-10-22       Impact factor: 5.285

Review 9.  Nutrient transporters: the Achilles' heel of anabolism.

Authors:  Alison N McCracken; Aimee L Edinger
Journal:  Trends Endocrinol Metab       Date:  2013-02-08       Impact factor: 12.015

10.  CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.

Authors:  Joseph M Cantor
Journal:  J Neuroimmunol       Date:  2014-06-26       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.